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of life in patients with gastrointestinal cancer (2 studies, n¼ 111, pooled
standard mean difference: 0.75, 95% confidence interval: 0.36–1.13).
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Abstract: Available systematic reviews showed uncertainty on the
effectiveness of using acupuncture and related therapies for palliative
cancer care.
The aim of this systematic review and meta-analysis was to sum-
marize current best evidence on acupuncture and related therapies for
palliative cancer care.
Five international and 3 Chinese databases were searched. Random-
ized controlled trials (RCTs) comparing acupuncture and related thera-
pies with conventional or sham treatments were considered. Primary
outcomes included fatigue, paresthesia and dysesthesias, chronic pain,
anorexia, insomnia, limb edema, constipation, and health-related quality
of life, of which effective conventional interventions are limited.
Thirteen RCTs were included. Compared with conventional inter-
ventions, meta-analysis demonstrated that acupuncture and related
therapies significantly reduced pain (2 studies, n¼ 175, pooled weighted
mean difference: 0.76, 95% confidence interval: 0.14 to 0.39)
among patients with liver or gastric cancer. Combined use of acupunc-
ture and related therapies and Chinese herbal medicine improved quality, Eric T. C. Ziea, P L. Ng, PhD,
Y. Wu, MD
cancer patients when compared with sham acupressure. Adverse events
for acupuncture and related therapies were infrequent and mild.
Acupuncture and related therapies are effective in reducing pain,
fatigue, and in improving quality of life when compared with conven-
tional intervention alone among cancer patients. Limitations on current
evidence body imply that they should be used as a complement, rather
than an alternative, to conventional care. Effectiveness of acupuncture
and related therapies for managing anorexia, reducing constipation,
paresthesia and dysesthesia, insomnia, and limb edema in cancer
patients is uncertain, warranting future RCTs in these areas.
(Medicine 95(9):e2901)
Abbreviations: CI = confidence interval, CIPN = chemotherapy-
induced peripheral neuropathy, NRS = numerical rating scale,
PSQI = Pittsburgh Sleep Quality Index, RCT = randomized
controlled trial, RR = relative risk, SR = systematic review, TFRS =
Tang Fatigue Rating Scale, VAS = visual analog scale.
INTRODUCTION
A cupuncture is one of the major treatment modalities inChinese medicine. It refers to a group of therapeutic
techniques characterized by needle insertion into the skin,
followed by either manual manipulation or electrical stimulation.
Related therapies like acupoints injection and needleless pro-
cedures like moxibustion and transcutaneous electrical nerve
stimulation are also often used separately or together with
acupuncture. Acupuncture and related techniques have been
widely used in managing various diseases and symptoms for
more than 2000 years. Multiple theories were proposed to explain
the mechanisms of actions, the most widely studied theory is the
endorphin theory, where acupuncture stimulated release of neu-
rotransmitter such as endorphin at spinal and supraspinal levels to
modulate various physiological responses,1,2 which the physio-
logical effects with acupuncture could be demonstrated by func-
tional magnetic resonance imaging studies.3 On the other hand,
1 theory suggested possible association of acupuncture points
with loose connective tissue anatomically.4 However, the exact
mechanism remains unclear.5–7
Multidimensional factors contribute to various symptoms
in cancer patients, including tumor invasion or metastasis,
anemia, polypharmacy, treatment side effects, hypogonadism
in male patients, autonomic dysfunction, and release of inflam-
matory cytokines.8–14 Fatigue is the most common complaint in
palliative cancer patients. Limited pharmaceutical agents suchproved their efficacy but they were
und side effects. Available evidence







results for each database are reported in Appendix 1, http://safe treatment modalities when they are delivered by adequately
trained practitioners.5–7 Acupuncture and related therapies are
widely used in palliative cancer care among Chinese popu-
lations,15 and are gaining popularity globally. Effectiveness of
these treatments, especially in the management of symptoms for
which conventional medicine has limited to offer, would be of
high interest among clinicians in palliative medicine. For
instance, the National Institute for Health stated that acupunc-
ture is a proven effective treatment modality for adult post-
operative and chemotherapy nausea and vomiting.16 Clinical
evidence on the potential effectiveness of acupuncture and
related therapies for controlling fatigue, paresthesia and dys-
esthesias, chronic pain, anorexia, insomnia, limb edema, and
constipation should be synthesized. Currently, 10 systematic
reviews (SRs) have been conducted to assess the role of
acupuncture and related therapies in palliative cancer care.
One meta-analysis showed effectiveness of acupuncture and
patient education on cancer-related fatigue.17 An SR demon-
strated that acupuncture is an effective treatment for chemother-
apy-induced nausea and vomiting, but its effectiveness for other
areas with unmet needs is uncertain.18 Results from SRs by Lee
et al19 and Bardia et al20 on treatment of cancer-related pain
showed insufficient evidence to support of refute the effective-
ness of acupuncture. One SR by O’Regan et al21 identified
potential roles of acupuncture in treatment of pain, nausea and
vomiting, xerostomia, hot flushes, fatigue, anxiety, depression,
and insomnia. Nevertheless, firm conclusion could not be drawn
as well.
The applicability of these available SRs is limited for a
number of reasons. First, some SRs had less restrictive
inclusion criteria for the study design, which included random-
ized controlled studies (RCTs), observational studies, and even
case series studies.19,22 Including studies with less rigorous
designs may jeopardize trustworthiness of the conclusion.
Second, details on the baseline treatment, as well as interven-
tions used in control groups were often not provided by either
the SR authors or the primary study authors.22 Poor reporting
makes it difficult to generalize evidence to clinical practice,
even when the intervention is found to be effective. Lastly,
many of these SRs were conducted more than 5 years ago.
New primary studies have been published during the last
5 years, and an up-to-date SR focusing on this area is
urgently needed.
We have conducted an updated SR on acupuncture and
related therapies for symptom management in palliative cancer
care. The objective of this study is to evaluate current best
evidence on the potential role of acupuncture and related
therapies in managing common cancer symptoms that pose
substantial challenges to conventional care, including fatigue,
paresthesia and dysesthesias, chronic pain, anorexia, insomnia,
limb edema, constipation, and health-related quality of life. In
order to overcome the shortcomings of previous SRs, strict
inclusion criteria on study design and reporting quality were
Lau et aladopted in the current SR. Evidence from this SR may support
the development of pragmatic collaboration model between
conventional and complementary medical practice.
METHODS
This SR and meta-analysis was reported according to the
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses checklist. Ethical approval was not necessary since all
the analyses were conducted based on data retrieved from
previous published SRs and trials.




To be included, the primary studies have to satisfy the
wing criteria:
Randomized controlled trials comparing acupuncture and/(1)
or related therapies with a valid comparison that allows
evaluation of the net effect of acupuncture and/or related
therapies.
Patients who are diagnosed with any type of cancer.
Any form of acupuncture or related techniques were
considered, including needle-based acupuncture (includ-
ing electroacupuncture), as well as other techniques,
including auricular acupuncture, laser acupuncture, acu-
pressure, acupoints injection, moxibustion, and transcu-
taneous electrical nerve stimulation.
Randomized controlled trials with control groups that have
used any type of interventions without acupuncture or
related treatments listed above. Control interventions may
include conventional treatment, behavioral therapies,
Chinese herbal medicine treatment, sham acupuncture,
waiting list, or no treatment.
Randomized controlled trials reporting 1 or more of the
following predefined primary outcomes measured with
validated instruments were included: fatigue, paresthesia
and dysesthesias, chronic pain, anorexia, insomnia, limb
edema, constipation, and health-related quality of life.
Randomized controlled trials that reported details on(6)
treatment prescription and follow-up duration for both
acupuncture and control group to ensure the usefulness of
synthesized evidence.
Literature Search
Comprehensive literature search was conducted by search-
ing both international and Chinese databases, including the
Cochrane Central Register of Controlled Trials, MEDLINE,
Embase, CINAHL Plus, the Allied and Complementary Medi-
cine Database,23 Chinese Biomedical Databases, Wanfang
Digital Journals, and Taiwan Periodical Literature Databases.
Specialized search filter for clinical trials were used in MED-
LINE24 and Embase.25 Detailed search strategies and relatedlinks.lww.com/MD/A726. No language restriction was set
during the literature search.
Literature Selection, Data Extraction, and Risk of
Bias Assessment
All the retrieved citations were screened and assessed for
their eligibility according to the inclusion criteria. The follow-
ing data were extracted from each included RCT: characteristics
of the study, including first author’s name, year of publication,
country in which the trial was conducted, eligibility criteria, and
sample size; details on patient characteristics, acupuncture and
related therapies, and control interventions and outcomes; effect
on each interested outcomes and adverse effects related to
acupuncture and related therapies; and information on risk
of bias.
Risk of bias of included RCTs were assessed with the latest
version of the Cochrane risk of bias tool,26 which assessed risk
of bias in the domains of sequence generation, allocationealment, blinding of participants and personnel, blinding
tcome assessments, incomplete outcome data, and selec-
utcome reporting. Each domain was judged to have low,
pyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
high, or unclear risk of bias according to information provided
by RCT authors.
Literature selection, data extraction, and risk of bias
assessment were performed by 2 researchers (XW, XL) inde-
pendently, with disagreement resolved by discussion and con-
Medicine  Volume 95, Number 9, March 2016sensus. A third reviewer (VCC) was consulted if disagreement
could not be resolved, and his judgment was used as the
final decision.
Data Analysis
Effectiveness was measured with relative risk (RR) for
dichotomous data and standardized mean difference, or
weighted mean difference for continuous data. Total 95%
confidence interval (CI) was used to account for the uncertainty
of the estimation. Random effects model was used to account
for the variations across trials27 during meta-analysis. I2 statistic
was used to measure the heterogeneity across trials. I2< 25%
was considered as low level of heterogeneity, 25% to 50% as
moderate level, and larger than 50% as high level.28 Funnel plot
would be used to detect the potential presence of publication
bias if more than 10 trials were available for 1 outcome.29 Stata
Version 13.0 (STATA Corporation, College Station, TX) was
Citation identified through electronic databa
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Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.used for the data analyses, with a 2-tailed significance level of





A total of 1704 citations were retrieved from the databases.
Total 237 duplicates and 1402 citations were excluded based on
title and abstract screening, and 65 citations were left for full-
text assessment. Fifty-two were excluded for the following
reasons: did not report prespecified outcomes (n¼ 20); the
add-on effect of acupuncture could not be evaluated as it
was not separated from other treatments (n¼ 7); no details
reported on baseline or acupuncture treatment (n¼ 7); no
acupuncture prescribed in the treatment group (n¼ 3); not a
RCT (n¼ 5); did not use validated instruments for outcome
assessment (n¼ 3); no details reported on time point for out-
come measurement (n¼ 4); and recruited both cancer and
Acupuncture for Palliative Cancer Care: Systematic Reviewnoncancer patients (n¼ 2). At last, 13 RCTs30–42 were
included. Details on the study selection process can be found
in Figure 1.
ses search (n=1704)
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Characteristics of Included Randomized
Controlled Trials
The 13 RCTs were published between 2005 and 2014, with
11 of them conducted in Mainland China, 1 in Taiwan and 1 in
Germany. Eight RCTs included various types of cancer patients,
and the remaining 5 RCTs were conducted in patients with
gastric cancer (n¼ 2), liver cancer (n¼ 1), lung cancer (n¼ 1),
and nonsmall cell lung cancer (n¼ 1). Various acupuncture
modalities were used among the 13 RCTs, including acupoint
injection (n¼ 4), needle acupuncture (n¼ 2), electroacupunc-
ture (n¼ 2), and moxibustion (n¼ 1), the remaining 4 trials
included more than 1 acupuncture modalities. As for the
comparisons, 7 RCTs assessed the effectiveness of acupuncture
and related therapies by comparing them with conventional
interventions, 5 investigated the effect of acupuncture and
related therapies as an add-on to conventional care, and the
remaining trial assessed the efficacy of acupuncture by compar-
ing it to sham acupuncture.
The most frequently reported outcome was pain (8 trials),
followed by quality of life (3 trials). Respectively, 1 RCT
reported evidence on constipation, anorexia, paresthesia and
dysesthesia, fatigue, and insomnia. Details on characteristics of
included RCTs are shown in Table 1.
Risk of Bias of Included Randomized Controlled
Trials
Majority of included RCTs had low risk of bias in the
domains of sequence generation (8 trials), incomplete outcome
data (9 trials), and selective outcome reporting (12 trials).
However, methods on allocation concealment and blinding
were poorly reported. Only 2 RCTs were judged to have low
risk of bias for allocation concealment, whereas the remaining
11 had unclear risk of bias. Due to difficulties in blinding and
subjective nature of interested outcomes, we judged 12 RCTs as
having high risk of bias for blinding of participants and per-
sonnel, and 8 as having high risk of bias for blinding of outcome
assessment. Only 1 RCT had low risk of bias for the 2 blinding-
related domains. Details are reported in Table 2.
EFFECTS OF ACUPUNCTURE AND
RELATED THERAPIES
Pain
Eight RCTs assessed the effect of acupuncture for reducing
pain in cancer patients. Two RCTs31–36 measured pain with
numerical rating scale (NRS), which measured pain with a 0 (no
pain) to 10 (most intolerable pain) scale. Meta-analysis showed
that, compared with conventional medicine (morphine sulfate
controlled-release tablets or World Health Organization’s 3-
step ladder for cancer pain relief), acupuncture and related
therapies significantly reduced pain (n¼ 175, weighted mean
difference: 0.76, 95% CI: 0.14 to 0.39, I2¼ 0.0%)
(Figure 2). Two RCTs31,41 also suggested that acupuncture
and related therapies had significantly shorter analgesic onset
time as compared with conventional medicine (morphine)
(Table 3). An RCT41 reported data on analgesic duration has
shown that, when compared with intramuscular injection of
morphine, acupoint injection of morphine had 7 additional
hours of analgesic duration (n¼ 115, mean difference [MD]:
7.29 hours, 95% CI: 6.27–8.31 hours) in patients with advance
Lau et alcancer (Table 3). Among the remaining 5 RCTs,32,35,37,38,40
although pain was measured with visual analog scale (VAS) or
NRS, results were reported as proportion of patient achieving
4 | www.md-journal.comsatisfactory relief instead of VAS or NRS changes. Better
effectiveness was described in acupuncture groups among all
5 studies, but no statistical significance was reached. Due to
differences in the cutoff used to define satisfactory relief, data
were not pooled in those 5 studies (Table 4).
Quality of Life
Four RCTs provided evidence on the effectiveness
of acupuncture and related therapies for improving quality of
life in cancer patients. Two studies34,42 reported quality of life-
related scores measured with validated scales (Karnofsky Per-
formance Status and Quality of Life Scale for cancer patients).
Meta-analysis showed that the combination use of acupuncture
and related therapies and Chinese herbal medicine slightly
improved quality of life in patients with gastrointestinal cancer
(n¼ 111, standardized mean difference: 0.75, 95% CI: 0.36–
1.13) (Figure 3). Another RCT32 (n¼ 32) reported that non-
small cell lung cancer patients who received the combination of
acupoints injection of Astragalus extract with 3-step analgesic
ladder medications had a significantly better quality of life than
patients who received 3-step analgesic ladder medications only
(33.3% versus 14.3%, RR: 2.00, 95% CI: 1.46–8.70) (Table 4).
Another RCT33 (n¼ 60) failed to find any difference in quality
of life among cancer patients who received electroacupuncture,
hydroelectric baths, vitamin B or vitamin B placebo.
Anorexia
One RCT34 (n¼ 50) assessed the add-on effect of needle
acupuncture on top of compounds Kushen injection for anorexia
in patients with advanced gastrointestinal cancer. After 4 weeks
treatment, a higher proportion of patients in the combined
treatment group showed improvement on anorexia (59.3%)
as compared with those who only received compounds Kushen
injection (17.4%). However, the difference did not reach stat-
istical significance (RR: 2.51, 95% CI: 0.94–6.72).
Constipation
An RCT39 (n¼ 100) assessed the effectiveness of acupoint
injection with vitamin B as compared with oral phenolphthalein
for reducing constipation caused by slow-release morphine
tablets. A higher proportion of patients in the acupoint injection
group showed improvement (92.0% versus 70.0%). However,
the difference was of no statistical significance (RR: 1.16, 95%
CI: 0.84–1.63).
Fatigue
A 3-arm RCT43 (n¼ 57) explored the efficacy of acupres-
sure plus essential oil, and acupressure alone for cancer-related
fatigue by comparing them with sham acupressure in lung
cancer patients. Fatigue was measured with Chinese versions
of the 37 items Tang Fatigue Rating Scale.44 Each item is rated
on a Likert scale ranging from 1 to 10, with higher scores
indicating more severe fatigue. Data from the acupressure plus
essential oil group and acupressure only groups were combined
during data analysis. After 5 months of treatment, patients in the
acupressure plus essential oil group and acupressure group
showed significantly lower fatigue score (MD: 0.63, 95%
CI: 1.22 to 0.04). We conducted sensitivity analysis within
study by excluding the acupressure group that had a high lost to
Medicine  Volume 95, Number 9, March 2016follow-up. Significant difference was still observed between
acupressure plus essential oil and sham acupressure group
(Table 3).
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lat
d t
Medicine  Volume 95, Number 9, March 2016 Acupuncture for Palliative Cancer Care: Systematic ReviewInsomnia
The same 3-arm RCT43 also investigated the efficacy of
acupressure plus essential oil, and acupressure alone for insom-
FIGURE 2. Meta-analysis on the effectiveness of acupuncture and re
with conventional medicine (comparison: acupuncture and relatenia in lung cancer patients. Sleep quality was measured with the
19-item Pittsburgh Sleep Quality Index.45 With each item rated
on a 0 to 3 Likert scale, a lower total score indicates better sleep
TABLE 3. Effectiveness of Acupuncture and Related Therapies for







Wang, 201016 Acupoint injectionþ needle
acupuncture versus morphine
Day








Tang, 201428 Acupressure or











Tang, 201428 Acupressure or
acupressureþ essential oil versus
sham acupressure
PSQI




Rostock, 201318 Electroacupuncture versus




(hydroelectric bath or vitamin B)
CIPN perceived severity
score, day 84
CI¼ confidence interval, CIPN¼ chemotherapy-induced peripheral neur
SD¼ standard deviation, TFRS¼Tang Fatigue Rating Score.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.quality. Results showed that after 5-month treatment, patients in
the acupressure plus essential oil and acupressure only group
had better quality of sleep than that of patients in the sham
ed therapies for reducing pain score in cancer patients as compared
herapies versus conventional medicine).acupressure group (Pittsburgh Sleep Quality Index score: 7.5
versus 10.1). However, this difference did not reach statistical
significance (MD: 0.57, 95% CI: 1.16 to 0.02) (Table 3).
Symptom Management in Cancer Palliative Care: Outcomes











2.03 (0.53) 30 3.69 (0.76) 30 2.53 (3.22, 1.85)
5.31 (4.98) 59 13.56 (3.47) 56 1.91 (2.36, 1.47)
9.21 (1.44) 59 10.35 (0.92) 56 7.29 (6.27, 8.31)
30.0 (71.5) 41 175.7 (75.0) 16 0.63 (1.22, 0.04)
22.9 (73.3) 17 175.7 (75.0) 16 0.71 (1.42, 0.01)
7.50 (4.47) 41 10.09 (4.76) 16 0.57 (1.16, 0.02)
7.53 (4.29) 17 10.09 (4.76) 16 0.57 (1.26, 0.13)
3.2 (1.9) 14 3.5 (2.4) 28 0.13 (0.78, 0.51)
3.4 (1.9) 14 3.7 (3.9) 28 0.09 (0.73, 0.55)
opathy MD¼mean difference, PSQI¼Pittsburgh Sleep Quality Index,
www.md-journal.com | 9
TABLE 4. Effectiveness of Acupuncture and Related Therapies for Symptom Management in Cancer Palliative Care: Outcomes
Measured as Dichotomous Data
Number of Patients in
Treatment Group
Number of Patients in
Control Group
First Author and








Chen, 200517 Acupoint injectionþ chemotherapyþ 3-step
analgesic ladder versus chemotherapyþ
3-step analgesic ladder
12 18 3 12 2.00 (0.66, 6.03)
Yang, 200520 Acupoint injection versus intramuscular
injection
26 26 22 26 1.09 (0.72, 1.64)
Chen, 200822 Needle acupuncture versus 3-step analgesic
ladder
32 34 28 32 1.04 (0.72, 1.50)
Yang, 201123 Electroauricular acupunctureþmorphine
versus morphine alone
57 60 44 50 1.04 (0.79, 1.38)
Li, 201125 Catgut implantation at
acupointþ acupunctureþ 3-step analgesic
ladder versus 3-step analgesic ladder alone
61 72 43 61 1.11 (0.83, 1.49)
Quality of life
Chen, 200517 Acupoint injectionþ chemotherapyþ 3-step
analgesic ladder versus chemotherapyþ
3-step analgesic ladder
15 18 6 14 2.00 (1.46, 8.70)
Anorexia
Li, 200619 Needle acupunctureþ conventional care versus
conventional care alone
26 27 16 23 2.51 (0.94, 6.72)
Constipation
Qin, 201024 Acupoint injection versus phenolphthalein 46 50 35 50 1.16 (0.84, 1.63)
Lau et al Medicine  Volume 95, Number 9, March 2016Paresthesia and Dysesthesia
A 4-arm RCT33 compared electroacupuncture with hydro-
electric baths, vitamin B and vitamin B placebo in managing
chemotherapy-induced peripheral neuropathy (CIPN) including
paresthesia among cancer patients. Severity of CIPN was
tablets
CI¼ confidence interval, RR¼ relative risk.measured with a NRS, scoring from 0 to 10, with a higher
score indicating higher severity of CIPN. During analysis, data
from hydroelectric baths and vitamin B groups were combined.
FIGURE 3. Meta-analysis on the add-on effect of acupuncture and relat
compared with conventional care alone (comparison: acupuncture
care alone).
10 | www.md-journal.comWhen compared with electroacupuncture group, no significant
difference was found at follow-up on 21 days (MD:0.13, 95%
CI: 0.78 to 0.51) or 84 days (MD: 0.09, 95% CI: 0.73 to
0.55).Adverse Events
Four RCTs31,35,41,42 reported information on adverse
events. Patients in control group generally had more adverse
ed therapies for improving quality of life score in cancer patients as
and related therapiesþ conventional care versus conventional
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
events than those in the acupuncture group. However, only
231,42 RCTs reported acupuncture induced side effects, includ-
ing dizziness during needle insertion (5/30), subcutaneous
Medicine  Volume 95, Number 9, March 2016bleeding (3/30), and mild burn, which was observed in few
cases when moxibustion was inappropriately conducted, which
was judged by the original RCT.27
DISCUSSION
Results from 13 RCTs with 969 cancer patients were
summarized in this SR. Acupuncture and related therapies
significantly reduced pain in cancer patients with a quicker
analgesic effect and longer analgesic duration when compared
with conventional medicine. Acupressure or acupressure plus
essential oil showed significant efficacy in reducing fatigue in
lung cancer patients when compared with sham acupressure.
Existing evidence also suggested that the additional use of
acupuncture and related therapies with conventional or Chinese
herbal medicine might improve quality of life in cancer patients.
Overall, acupuncture and related therapies only caused minor
side effects. On the other hand, available evidence did not show
any differences on the following comparisons: the combined
use of acupuncture and conventional care versus conventional
care alone for treating anorexia; acupuncture and related thera-
pies versus conventional medicine for reducing constipation,
paresthesia and dysesthesia; and acupressure or acupressure
plus essential oil versus sham acupressure for improving
insomnia.
This SR has presented an updated view on the clinical
applicability of acupuncture and related therapies for symptom
management, especially in controlling pain and fatigue.
Previous SRs19,20,46 showed inconclusive results for the effi-
cacy of acupuncture and related therapies in cancer pain control
due to a lack of ‘‘high quality’’ studies. Results from our SR
suggested clinicians may consider acupuncture and related
therapies for cancer related pain, in particular when pain control
is unsatisfactory under conventional care, or when patients are
experiencing significant side effects induced by analgesic
medications. Regarding alleviation of cancer-related fatigue,
1 previous meta-analysis17 demonstrated statistical significant
improvement with acupuncture and patient education when
compared with conventional care. However, whether the effect
was attributable to acupuncture or patient education could not
be well delineated. Fatigue is a well acknowledged undertreated
symptom in cancer patients due to lack of effective options in
conventional medicine.47 Our results suggest the practice of
acupressure alone or in combination with essential oil can be an
alternative or adjuvant treatment for cancer-related fatigue.
Risk of bias among the included RCTs should be carefully
assessed. The majority of them did not provide information on
how allocation concealment and blinding were ensured, results
in high risk of ascertainment bias. On the other hand, bias could
be further reduced if the outcomes were assessed by blinded29
investigators.29 Unfortunately, the majority of included RCTs
did not specify whether the investigators analyzing outcomes
were blinded except for 1 trial on fatigue and insomnia.30 These
reflected poor adherence of the Consolidated Standards of
Reporting Trials reporting requirements48 among these RCTs.30
Another limitation of the reviewed evidence is that, due to
small number of included studies for each outcome, we are
unable to evaluate the presence or absence of publication bias.
The majority of the included studies were conducted in Chinese
populations either from Mainland China or Taiwan. Evidence
users should consider potential heterogeneity among different
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.ethnicities and settings when adopting acupuncture and related
therapies for their own practice.
Based on limitations of the included RCTs, several recom-
mendations are made for further research. First, with the
emergence of integrative medicine, acupuncture and related
therapies are usually used as an adjuvant therapy on top of
conventional care in real clinical settings. Hence, comparing
acupuncture alone with standard care or sham acupuncture
alone may only generate results with limited external validity.
Conducting pragmatic trials that compare acupuncture plus
standard care versus standard care alone may provide results
that can directly inform clinical practice.46 Second, future RCTs
should use validated instruments for measuring outcomes.
Amendments of instruments were not uncommon among
included trials and this practice should be discouraged. For
example, although all the 8 RCTs that reported data on pain
used VAS or NRS, 5 of them summarized their results as
dichotomous data according to self-developed rules. This
reduces the interpretability of their results, and reporting bias
of the outcomes is highly suspected. Third, future trials should
evaluate the effect of acupuncture and related therapies in
managing other important symptoms, including limb edema
of which we did not locate any RCTs. Lastly, future RCTs
should report adverse effect comprehensively so as to facilitate
the safety assessment.
In conclusion, our meta-analyses demonstrated that acu-
puncture and related therapies showed a significant analgesic
effect in terms of reducing pain score, providing quicker
analgesic effect, and longer analgesic duration in cancer
patients when compared with conventional medicine alone.
However, these results are not in line with the rest of the
evidence body in the area.49 Acupuncture and related therapies
can be considered as an adjunct, instead of a replacement to,
conventional pain management protocol for cancer palliative
care patients.
Acupressure or acupressure plus essential oil showed
efficacy in improving fatigue in lung cancer patients. The
combined use of acupuncture and related therapies with con-
ventional medications or Chinese herbal medicine can improve
quality of life among cancer patients. The effectiveness of
acupuncture and related therapies in treating anorexia, consti-
pation, paresthesia and dysesthesia, insomnia, and limb edema
in cancer patients is unclear. As a relatively safe modality,
acupuncture could be considered as an adjuvant options for the
management of pain, fatigue, and improving quality of life in
cancer patients. On the other hand, safety of acupoint injection
and moxibustion would require further investigation. Future
research should pay attention on: choosing appropriate control
interventions that reflect real clinical practice; using validated
outcome measurement instrument without unwarranted amend-
ments; blinding the outcome assessors to reduce potential bias;
and reporting the RCTs in accordance to the Consolidated
Standards of Reporting Trials statement.48
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